Can’t charge exorbitant fees for something trivial to produce.
I’d probably respond to your tone and assumptions with a string of vulgar invective containing ‘cope’, ‘nerd’, ‘sneed’ etc but I now realize this forum is not the place.
Read up on escitalopram and esketamine. Both are racemic separations of the original compound (with anti-depressive properties). Biochemically/medically they're basically identical to the original citalopram and ketamine. Same effect, same side effect. They're literally just the active half of the original compound. But legally a racemic separation which is medically equivalent is still juuuust different enough chemically you can patent it.
It seems highly likely to me that a pharma company is going to design and patent a psilocin prodrug with nearly identical effects to mushrooms, that's patentable, and they'll charge tidily for it. (Psilocybin itself in mushrooms is just a prodrug for psilocin.) I suspect if that happens psilocin or psilocybin will never be approved for routine use.
Heroin, fentanyl, opiates, amphetamines, benzos, are all chemically organic, that doesn't mean shit for how they should or shouldn't be used, neither in research nor medically nor recreationally.